Article Sidebar
Main Article Content
Abstract
Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.
Keywords
Article Details
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Becker, K. L., Snider, R. and Nylen, E. S. (2008) ‘Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations’, Critical Care Medicine, 36(3), pp. 941–952. doi: 10.1097/CCM.0B013E318165BABB.
Cai, X. et al. (2021) ‘Relationship between lactate dehydrogenase and albuminuria in Chinese hypertensive patients’, J Clin Hypertens, 23, pp. 128–136. doi: 10.1111/jch.14118.
Chen, N. et al. (2020) ‘Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study’, The Lancet. Elsevier Ltd, 395(10223), pp. 507–513. doi: 10.1016/S0140-6736(20)30211-7.
Christensen, B. et al. (2020) ‘Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)’, Semin Thromb Hemost, 46, pp. 845–849. doi: 10.1055/s-0040-1715458.
Conti, P. and Younes, A. (2020) ‘Coronavirus cov-19/sars-cov-2 affects women less than men: Clinical response to viral infection’, Journal of Biological Regulators and Homeostatic Agents, 34(2), pp. 339–343. doi: 10.23812/Editorial-Conti-3.
Ding, X. et al. (2020) ‘Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019’, Clinical Chemistry and Laboratory Medicine, 58(8), pp. 1365–1371. doi: 10.1515/cclm-2020-0411.
Fachri, M. et al. (2022) ‘Correlations between comorbidities, chest x-ray findings, and C-Reactive protein level in patients with COVID-19’, Annals of Medicine and Surgery. Elsevier Ltd, 77(April), p. 103553. doi: 10.1016/j.amsu.2022.103553.
Fan, L. et al. (2020) ‘Progress and prospect on imaging diagnosis of COVID-19 • Imaging • Viral pneumonia • Artificial intelligence’, Chinese Journal of Academic Radiology, 3, pp. 4–13. doi: 10.1007/s42058-020-00031-5.
Gemmati, D. et al. (2020) ‘COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?’, Int. J. Mol. Sci, 21, p. 3474. doi: 10.3390/ijms21103474.
Guan, W. et al. (2020) ‘Clinical Characteristics of Coronavirus Disease 2019 in China’, New England Journal of Medicine, 382(18), pp. 1708–1720. doi: 10.1056/nejmoa2002032.
Henry, B. M. and Lippi, G. (2020) ‘Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection’, International Urology and Nephrology, 52, pp. 1193–1194. doi: 10.1007/s11255-020-02451-9.
Hidayati, D. (2020) ‘Profil Penduduk Terkonfirmasi Positif Covid-19 Dan Meninggal: Kasus Indonesia Dan Dki Jakarta’, Jurnal Kependudukan Indonesia, 2902, p. 93. doi: 10.14203/jki.v0i0.541.
Karyono, D. R. and Wicaksana, A. L. (2020) ‘Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia’, Journal of Community Empowerment for Health, 3(2), p. 77. doi: 10.22146/jcoemph.57325.
Klein, S. L. and Flanagan, K. L. (2016) ‘Sex differences in immune responses’, Nature Reviews Immunology. Nature Publishing Group, 16(10), pp. 626–638. doi: 10.1038/nri.2016.90.
Lippi, G. and Plebani, M. (2020) ‘Letter to the Editor Laboratory abnormalities in patients with COVID-2019 infection’, Clin Chem Lab Med, 58(7), pp. 1131–1134. doi: 10.1515/cclm-2020-0198.
Liu, F. et al. (2020) ‘Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19’, Journal of Clinical Virology. Elsevier, 127(April), p. 104370. doi: 10.1016/j.jcv.2020.104370.
Mardani, R. et al. (2020) ‘Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study’, Archives of Academic Emergency Medicine, 8(1), p. e43. doi: 10.22037/aaem.v8i1.632.
Mardewi, I. G. A. and Yustiani, N. T. (2021) ‘Gambaran hasil laboratorium pasien COVID-19 di RSUD Bali Mandara: sebuah studi pendahuluan’, Intisari Sains Medis | Intisari Sains Medis, 12(1), pp. 374–378. doi: 10.15562/ism.v12i1.933.
Miri, C. et al. (2021) ‘D-dimer Level and Diabetes in the COVID-19 Infection’, Clinical and Applied Thrombosis/Hemostasis, 27, pp. 1–4. doi: 10.1177/10760296211045902.
Nabila, A., Puspitasari, C. E. and Erwinayanti, G. A. . S. (2020) ‘Jurnal Sains dan Kesehatan’, Jurnal Sains dan Kesehatan, 3(1), pp. 242–247.
Pourbagheri-Sigaroodi, A. et al. (2020) ‘Laboratory findings in COVID-19 diagnosis and prognosis’, Clinica Chimica Acta, 510(June), pp. 475–482. doi: 10.1016/j.cca.2020.08.019.
Schurz, H. et al. (2019) ‘The X chromosome and sex-specific effects in infectious disease susceptibility’, Human genomics. Human Genomics, 13(1), p. 2. doi: 10.1186/s40246-018-0185-z.
Shang, W. et al. (2020) ‘The value of clinical parameters in predicting the severity of COVID-19’, J Med Virol, 92, pp. 2188–2192. doi: 10.1002/jmv.26031.
Sim, B. L. H. et al. (2020) ‘Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study’, The Lancet Regional Health - Western Pacific. Elsevier Ltd, 4, p. 100055. doi: 10.1016/j.lanwpc.2020.100055.
Smeltzer, S. C. and Bare, B. G. (2017) Textbook of Medical-Surgical Nursing. doi: 10.1057/palgrave.im.4340237.
Suhatri, S. et al. (2014) ‘Efek Proteksi Fraksi Etil Asetat Daun Surian (Toona sureni (Blume) Merr. ) terhadap Aterosklerosis’, Jurnal Sains Farmasi & Klinis, 1(1), p. 10. doi: 10.29208/jsfk.2014.1.1.20.
Susilo, A. et al. (2020) ‘Coronavirus Disease 2019 : Tinjauan Literatur Terkini Coronavirus Disease 2019 : Review of Current Literatures’, Jurnal Penyakit Dalam Indonesia, 7(1), pp. 45–67.
Tan, L. et al. (2020) ‘Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study’, Med. Elsevier Inc., 1(1), pp. 128–138. doi: 10.1016/j.medj.2020.05.002.
Terpos, E. et al. (2020) ‘Hematological findings and complications of COVID-19’. doi: 10.1002/ajh.25829.
Wang, R. R., He, M. and Kang, Y. (2021) ‘A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients’, J Clin Lab Anal, 35. doi: 10.1002/jcla.23805.
Williamson, E. J. et al. (2020) ‘Factors associated with COVID-19-related death using OpenSAFELY’, Nature, 584, p. 430. doi: 10.1038/s41586-020-2521-4.
Yang, J. et al. (2020) ‘Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis’, International Journal of Infectious Diseases, 94, pp. 91–95. doi: 10.1016/j.ijid.2020.03.017.
Zhang, H. et al. (2020) ‘Clinical and hematological characteristics of 88 patients with COVID-19’, Int J Lab Hematol, 42, pp. 780–787. doi: 10.1111/ijlh.13291.
Zhang, J. et al. (2020) ‘Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China’, Journal of Clinical Virology. Elsevier, 127(April), p. 104392. doi: 10.1016/j.jcv.2020.104392.